Moderna plant nicht, in neue Impfstoffversuche im Spätstadium zu investieren, da der Widerstand von US-Beamten gegen Impfungen wächst

* Moderna Inc.’s chief executive officer said the company doesn’t plan to invest in new late-stage vaccine trials due to growing opposition to immunizations from US officials.
* Regulatory delays and lack of support from US health officials are making the potential market size „much smaller“, according to Stéphane Bancel.
* US officials have narrowed the population eligible for Covid vaccines, created confusion over how to get them and raised questions over their safety under the leadership of Health Secretary Robert F. Kennedy Jr.